MaxCyte (MXCT) said Monday it has completed an operational review which resulted in a 15% reduction of its workforce, affecting 21 positions and saving about $5.8 million in 2025.

The layoffs and other personnel decisions will bring its headcount to 116 employees by the end of 2024, compared with 143 at the end of 2023, the company said.

MaxCute also raised its full-year 2024 core revenue guidance to 6% to 8% growth, up from its previous guidance of at least 5% growth.

Analysts polled by FactSet expect sales of $37.7 million.